Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1127334

registered interest
date	17/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Isotretinoin: Side Effects
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential health risks and psychiatric side-effects of the drug Roaccutane.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	255661
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>As with all medicines in the United Kingdom, the Medicines and Healthcare products Regulatory Agency continuously monitors the safety of isotretinoin-containing medicines. This includes reports of suspected adverse drug reactions submitted by healthcare professionals, patients and carers through the Yellow Card scheme, as well as published and unpublished data. As new evidence on safety emerges it is carefully evaluated and, where appropriate, product information is updated and advice for prescribers and patients is issued.</p><p>Specific assessments of possible psychiatric side effects associated with isotretinoin were considered by an Expert Working Group of the Commission on Human Medicines in 2005 and 2014. In addition, the risk of neuropsychiatric disorders was evaluated in a European review which was completed in 2018. This review concluded that the warnings in the product information for medicines containing isotretinoin regarding possible psychiatric adverse effects reflected what was known.</p><p>Since 1998, warnings regarding the possible risk of developing depression and other psychiatric side effects have been included in the product information for Roaccutane and the generic versions of isotretinoin (the Summary of Product Characteristics for healthcare professionals and the patient information leaflet). The product information for isotretinoin warns that treatment may be associated with possible psychiatric side effects, that particular care needs to be taken in patients with a history of depression; and that all patients on isotretinoin should be monitored for signs of depression and referred for appropriate treatment if necessary. It also states that stopping isotretinoin may not lead to improvement and therefore further psychiatric or psychological evaluation may be necessary.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 22/05/2019 16:42:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1436 label Biography information for Paul Farrelly

1127147

registered interest
date	16/05/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Females: Directors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate his Department has made of the number of women in senior roles at UK energy companies.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	255270
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>Government does not make assessments of the number of women in senior roles at UK energy companies, but alongside sponsoring the Hampton-Alexander Review on FTSE Women Leaders and promoting diversity in the energy sector, we support the work of POWERful Women which collates data on gender diversity in senior and middle management levels in the energy sector - which can be found at: <a href="http://powerfulwomen.org.uk/board-statistics-by-company/" target="_blank">http://powerfulwomen.org.uk/board-statistics-by-company/</a></p><p>Strong progress has been made in that the representation of women on FTSE 100 boards has increased from 12.5% in 2011 to 31.6% in May 2019 and among executive directors has doubled from 5.5% to 10.3% in the same period.</p><p> </p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst question first answered 22/05/2019 16:20:15 answering member 4487 label Biography information for Kelly Tolhurst previous answer version 119452 answering member constituency Rochester and Strood answering member printed Kelly Tolhurst answering member 4487 label Biography information for Kelly Tolhurst
tabling member	308 label Biography information for Mr Jim Cunningham

1126962

registered interest
date	15/05/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Construction: Trading Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the effectiveness of Trading Standards in protecting consumers from rogue and incompetent builders in the construction industry.
tabling member constituency	Morecambe and Lunesdale
tabling member printed	David Morris
uin	254821
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>No such assessment has been made, but the Government is considering options to ensure that our system of consumer protection provides a robust response to both local and national threats for the Consumer White Paper.</p><p> </p><p>The Government has endorsed the TrustMark scheme to reduce the number of rogue and incompetent builders; and to identify local traders who have undergone independent checks for both trade competence and good trading practice. This scheme gives consumers increased confidence and ability to choose registered businesses including builders who adhere to and maintain high standards.</p><p> </p><p>TrustMark is actively involved with Trading Standards to provide further protection to consumers affected by rogue builders.</p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst question first answered 22/05/2019 16:20:22 answering member 4487 label Biography information for Kelly Tolhurst previous answer version 119032 answering member constituency Rochester and Strood answering member printed Kelly Tolhurst answering member 4487 label Biography information for Kelly Tolhurst
tabling member	4135 label Biography information for David Morris

1126970

registered interest
date	15/05/2019
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Trials: Ethnic Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, what recent estimate he has made of the proportion of (a) BAME and (b) white defendants who enter guilty pleas.
tabling member constituency	Bolton South East
tabling member printed	Yasmin Qureshi
uin	254792
answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The proportion of guilty pleas (where plea was known) has slowly been declining, from 74% in 2014 to 69% for white defendants, and from 61% in 2014 to 57% for BAME defendants in 2018.</p><p>Data is only available for defendants dealt with at Crown Court (not all defendants) for indictable offences.</p><p>The proportion of defendants who entered a guilty plea by ethnicity (2008 – 2018) can be found in the Crown court data tool at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/802313/crown-court-tool-2018.xlsx" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/802313/crown-court-tool-2018.xlsx</a></p><ul><li>Remove the ‘Values’ field from Rows</li><li>Drag the ‘Ethnicity’ field into Rows</li><li>Drag the ‘Total for Trial’ field into Values</li><li>Filter to ’01: Guilty Plea’ in the ‘Plea at Crown Court’ field for the number of defendants that entered a guilty plea</li><li>Filter to ’01: Guilty Plea’ and ’02: Not Guilty plea’ in the ‘Plea at Crown Court’ field number of defendants that entered a plea overall (where plea was known)</li><li>The number of BAME defendants can be defined by combining ’02: Black’, ’03: Asian’, ’04: Mixed’ and ’05: Chinese and other’ rows. The number of white defendants who entered a guilty plea each year can be found in the ‘01: White’ row.</li><li>The proportion of defendants who entered a guilty plea can be found by dividing the number of guilty pleas by the number of overall pleas for the relevant ethnicity rows.</li></ul> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/05/2019 16:46:56 answering member 4362 label Biography information for Edward Argar
tabling member	3924 label Biography information for Yasmin Qureshi